Харвестер відкритої науки НАН України

The JAK2 V617F mutation in lung cancer: caveat emptor

за авторством Langabeer, S.E.
Опубліковано 2018

Frequency and spectrum of atypical BCR-ABL1 transcripts in chronic myeloid leukemia

за авторством Kearney, L., Crampe, M., Langabeer, S.E.
Опубліковано 2023

ATYPICAL BRAF MUTATIONS IN HAIRY CELL LEUKEMIA: DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS

за авторством LANGABEER, S.E., CROTTY, G., BACON, C.L.
Опубліковано 2025

Anagrelide and the CALR mutation allele burden in essential thrombocythemia

за авторством Atkinson, E., Bakri, M., Hayat, A., Langabeer, S.E.
Опубліковано в: Experimental Oncology (2018)

Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia

за авторством Langabeer, S.E., Haslam, K., Crampe, M., MacDonagh, B., McHugh, J.
Опубліковано 2023